A drop of blood could soon reveal dozens of diseases. The NasRED test is fast, cheap, and accurate—here’s what you need to ...

With Theranos, she promised to run hundreds of tests with just a finger-prick of blood. In 2015 a series of damning reports by former Wall Street Journal reporter John Carreyrou exposed the blood ...

Theranos, the blood testing startup based in Palo Alto, Calif., ran a hematology test on 81 patients in a six-month period despite erratic results from quality-control checks, according to The ...

Theranos retracted two years of tests conducted on its proprietary “Edison” device last month and it is now saying these tens of thousands of voided or corrected tests account for less than 1 ...

Theranos promised to revolutionize healthcare with a device that could run hundreds of tests from a single drop of blood.

Skepticism is rational. We must clear a higher bar," the company wrote. "This is not Theranos 2.0. Theranos attempted to miniaturize existing tests. Our approach is fundamentally different.

In a new consent decree, attorneys for Theranos denied the company violated the state’s Consumer Fraud Act in selling blood tests where the results were not always accurate. Attorneys for the ...

Forget Theranos. There’s now a BetterWay to do diagnostic tests via small blood samples. While Theranos founder Elizabeth Holmes serves an 11-year prison sentence for fraud in Bryan, Texas ...

Theranos, the 12-year-old Palo Alto-based company working on a smaller, cheaper, alternative to common lab blood tests, has received its first voluntary FDA 510(k) clearance, for its herpes simplex 1 ...

Palo Alto-based novel blood test company Theranos was granted a waiver from the FDA allowing the company to offer its first FDA-cleared blood test, its herpes simplex 1 virus IgG (HSV IgG) test, ...

The company's futuristic blood-testing tech, it seemed, failed to deliver on its promise. Theranos was first sued by Walgreens for breach of contract in 2016, just over a year after the article was ...

4. A series of Wall Street Journal articles dating back to October 2015 reported that Theranos performed the vast majority of its 200-plus blood tests using traditional off-the-shelf laboratory ...